12.08
price down icon1.06%   -0.13
pre-market  Pre-market:  12.99   0.91   +7.53%
loading
Delcath Systems Inc stock is traded at $12.08, with a volume of 213.50K. It is down -1.06% in the last 24 hours and down -25.80% over the past month. Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$12.21
Open:
$12.44
24h Volume:
213.50K
Relative Volume:
0.55
Market Cap:
$403.51M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-4.2837
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
-8.62%
1M Performance:
-25.80%
6M Performance:
+26.62%
1Y Performance:
+215.40%
1-Day Range:
Value
$11.80
$12.44
1-Week Range:
Value
$11.11
$13.85
52-Week Range:
Value
$3.70
$16.97

Delcath Systems Inc Stock (DCTH) Company Profile

Name
Name
Delcath Systems Inc
Name
Phone
(518) 743-8892
Name
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Name
Employee
76
Name
Twitter
@delcathsystems
Name
Next Earnings Date
2024-11-08
Name
Latest SEC Filings
Name
DCTH's Discussions on Twitter

Compare DCTH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
DCTH
Delcath Systems Inc
12.08 403.51M 2.07M -47.68M -31.31M -2.82
Medical Devices icon
ABT
Abbott Laboratories
129.89 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.37 140.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
363.66 138.77B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
92.33 118.39B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
67.95 39.95B 5.72B 4.17B 259.90M 6.97

Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-28-24 Initiated Craig Hallum Buy
May-14-24 Initiated Stephens Overweight
Jul-26-22 Resumed Canaccord Genuity Buy
Dec-10-21 Initiated H.C. Wainwright Buy
Mar-09-21 Initiated Canaccord Genuity Buy
Jan-05-21 Initiated BTIG Research Buy
Jun-01-20 Initiated Laidlaw Buy
View All

Delcath Systems Inc Stock (DCTH) Latest News

pulisher
Mar 13, 2025

Delcath Systems Reports Strong 2024 Financial Growth - TipRanks

Mar 13, 2025
pulisher
Mar 12, 2025

Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2024 Earnings Call Transcript - MSN

Mar 12, 2025
pulisher
Mar 11, 2025

With A 27% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For - Simply Wall St

Mar 11, 2025
pulisher
Mar 10, 2025

Delcath Systems’ Earnings Call Highlights Strong Growth and Strategic Expansion - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

HC Wainwright Estimates Delcath Systems FY2029 Earnings - Defense World

Mar 10, 2025
pulisher
Mar 10, 2025

Delcath Systems (NASDAQ:DCTH) Price Target Raised to $24.00 - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance UK

Mar 08, 2025
pulisher
Mar 08, 2025

Private Advisor Group LLC Acquires New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Positive Outlook for Delcath Systems: Promising Growth and Strategic Expansion Drive Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Delcath stock price target raised to $24 by H.C. Wainwright - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Strong Growth Potential for Delcath Systems: Buy Rating Affirmed with Raised Price Target - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Delcath Systems reports net loss of USD 3.4M in Q4 2024 - Medical Buyer

Mar 07, 2025
pulisher
Mar 07, 2025

Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Delcath Systems Inc (DCTH) Q4 2024 Earnings Call Highlights: Strong HEPZATO Revenue and ... - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Delcath Systems Braces for Financial Impact Amid Uncertain Tax Law Changes - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue Estimates - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

BTIG lifts Delcath Systems stock target to $22, maintains buy By Investing.com - Investing.com Canada

Mar 06, 2025
pulisher
Mar 06, 2025

BTIG lifts Delcath Systems stock target to $22, maintains buy - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Delcath Systems reports Q4 EPS (11c), consensus 1c - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Delcath Systems Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

DELCATH SYSTEMS, INC. SEC 10-K Report - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

Earnings call transcript: Delcath Systems Q4 2024 results show mixed performance - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Delcath Systems Inc (DCTH) Q4 Earnings: Revenue Surpasses Estima - GuruFocus.com

Mar 06, 2025
pulisher
Mar 06, 2025

Delcath Systems Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

Can Delcath's 30x Revenue Growth and FDA Trial Approval Transform Cancer Treatment? - StockTitan

Mar 06, 2025
pulisher
Mar 06, 2025

Delcath Systems, Inc. (NASDAQ:DCTH) Shares Acquired by Principal Financial Group Inc. - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Carcinoid Tumor Treatment Market Size in the 7MM is expected - openPR

Mar 05, 2025
pulisher
Mar 04, 2025

Delcath Systems Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

(DCTH) Proactive Strategies - Stock Traders Daily

Mar 04, 2025
pulisher
Mar 03, 2025

The future of U.S. medical devices companies amid tariff impositions (IHI:NYSEARCA) - Seeking Alpha

Mar 03, 2025
pulisher
Feb 28, 2025

Is Corcept Therapeutics (CORT) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Delcath Systems (DCTH) Expected to Announce Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 25, 2025

Painful week for retail investors invested in Delcath Systems, Inc. (NASDAQ:DCTH) after 14% drop, institutions also suffered losses - Simply Wall St

Feb 25, 2025
pulisher
Feb 21, 2025

Where are the Opportunities in (DCTH) - Stock Traders Daily

Feb 21, 2025
pulisher
Feb 20, 2025

Liver Cancer Treatment Pioneer Delcath Reports Q4 Earnings: Will Growth Continue? - StockTitan

Feb 20, 2025
pulisher
Feb 18, 2025

Intrahepatic Cholangiocarcinoma Market: Analysis - openPR

Feb 18, 2025
pulisher
Feb 17, 2025

Here's What Could Help Delcath Systems (DCTH) Maintain Its Recent Price Strength - Nasdaq

Feb 17, 2025
pulisher
Feb 14, 2025

Delcath Systems Announces Update To National Comprehensive Cancer Network Clinical Practice Guidelines - Marketscreener.com

Feb 14, 2025
pulisher
Feb 14, 2025

Delcath Systems Announces Update to National Comprehensive Cance - WICZ

Feb 14, 2025
pulisher
Feb 14, 2025

Major Treatment Breakthrough: NCCN Widens Access to Revolutionary Melanoma Therapy - StockTitan

Feb 14, 2025
pulisher
Feb 12, 2025

Are You Looking for a Top Momentum Pick? Why Delcath Systems, Inc. (DCTH) is a Great Choice - MSN

Feb 12, 2025
pulisher
Feb 10, 2025

Delcath Delivers 100% Gain In Less Than 6 Months - RTTNews

Feb 10, 2025
pulisher
Feb 08, 2025

Analysts Say Delcath Systems Inc Can Reach $22 In 12 Months - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 07, 2025

Delcath Systems: Strong Position In Metastatic Uveal Melanoma, But Broader Growth Challenges Ahead - Seeking Alpha

Feb 07, 2025
pulisher
Feb 06, 2025

Wall Street Analysts Think Delcath Systems (DCTH) Could Surge 33.74%: Read This Before Placing a Bet - Nasdaq

Feb 06, 2025
pulisher
Feb 06, 2025

How should investors view Delcath Systems Inc (DCTH)? - US Post News

Feb 06, 2025
pulisher
Feb 04, 2025

Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Delcath Systems, Inc. - AOL

Feb 04, 2025
pulisher
Feb 04, 2025

16,978 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Baader Bank Aktiengesellschaft - MarketBeat

Feb 04, 2025
pulisher
Feb 02, 2025

Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat

Feb 02, 2025

Delcath Systems Inc Stock (DCTH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$107.57
price up icon 3.40%
medical_devices STE
$222.45
price down icon 0.89%
medical_devices PHG
$26.11
price down icon 2.03%
$68.48
price down icon 3.22%
$81.45
price down icon 2.79%
medical_devices EW
$67.95
price down icon 0.82%
Cap:     |  Volume (24h):